Language: BG BG
← Back to results
Recruiting NCT06212947

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

Conditions: Hypochondroplasia

Sponsor: BioMarin Pharmaceutical

trial.available_in: БГ
Overview
This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.
Who can participate
Inclusion Criteria: * Participants must be ≤ 15 years old at the time of signing the informed consent * Participants must have genetic confirmation of Hypochondroplasia diagnosis Exclusion Criteria: * Have a diagnosis of another genetic short stature condition other than Hypochondroplasia or a genetic variant known to cause another genetic syndrome associated with short stature * Received an investigational product or medical device within 6 months before the Screening visit
Locations 11
Argentina (1)
Hospital de Pediatria SAMIC Prof. Dr. Juan P Garrahan
Buenos Aires
NOT_YET_RECRUITING
Australia (1)
Royal Children's Hospital Melbourne
Parkville , Victoria
Brazil (1)
Hospital de Clinicas de Porto Algre
Porto Alegre , Rio Grande Do Sol
NOT_YET_RECRUITING
Canada (1)
Stollery Children's Hospital
Edmonton , Alberta
France (1)
Hospices Civils de Lyon - Hôpital Femme Mère Enfant
Lyon
Germany (1)
Uniklinik Koln
Cologne
Italy (1)
Istituto Giannina Gaslini
Genoa , Liguria
Japan (1)
Kumamoto University Hospital
Kumamoto , Kumamoto
Spain (1)
Hospital Universitario La Paz
Madrid
United Kingdom (1)
Great Ormond Street Hospital for Children NHS Foundation Trust
London , England
United States (1)
Phoenix Children's Hospital
Phoenix , Arizona
Technical details
Status
Recruiting
Study type
OBSERVATIONAL
Sex
Male and female
Maximum age
15 Years
Healthy volunteers
No
Start date
27.11.2023
Completion date
31.12.2043
Registry ID
NCT06212947
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.